Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07490080Terminated

Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis

Role: lead

NCT06276270Not ApplicableCompleted

Multi-centre, Open-label, First-in-man Study With Mucopad HA

Role: lead

NCT07065110Not ApplicableCompleted

The Effect of Peroral Sodium Hyaluronate on the Skin

Role: lead

NCT05618496Not ApplicableCompleted

Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients

Role: lead

NCT05625984Not ApplicableCompleted

Study With Fascigel

Role: lead

NCT04091399Phase 2Completed

First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro

Role: lead

All 6 trials loaded